Comparison of inhibitors of renin–angiotensin–aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function
Comparison of inhibitors of renin–angiotensin–aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function
The adaptation of steroid therapy and the effect of renin–angiotensin–aldosterone system inhibitors (RASIs) for advanced immunoglobulin
A nephropathy (IgAN) patients with impaired renal function are still controversial.
知识与财富的链接
